curcumin and Respiratory-Syncytial-Virus-Infections

curcumin has been researched along with Respiratory-Syncytial-Virus-Infections* in 3 studies

Other Studies

3 other study(ies) available for curcumin and Respiratory-Syncytial-Virus-Infections

ArticleYear
Anti-inflammatory effects of curcumin-loaded niosomes on respiratory syncytial virus infection in a mice model.
    Journal of medical microbiology, 2022, Volume: 71, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Child; Curcumin; Disease Models, Animal; Female; Humans; Liposomes; Lung; Mice; Mice, Inbred BALB C; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human

2022
Synergistic antiviral effect of curcumin functionalized graphene oxide against respiratory syncytial virus infection.
    Nanoscale, 2017, Oct-26, Volume: 9, Issue:41

    The diseases attributable to viruses remain a global burden. The respiratory syncytial virus (RSV), which is considered as the major viral pathogen of the lower respiratory tract of infants, has been implicated in severe lung disease. In this contribution, we developed a β-cyclodextrin (CD) functionalized graphene oxide (GO) composite, which displayed excellent antiviral activity and could load curcumin efficiently. RSV, a negative-sense single-stranded enveloped RNA virus, was employed as a model virus to investigate the antiviral activity of multifunctional GO. Proved by the tissue culture infectious dose assay and immunofluorescence assay, the curcumin loaded functional GO was confirmed with highly efficient inhibition for RSV infection and great biocompatibility to the host cells. The results showed that the composite could prevent RSV from infecting the host cells by directly inactivating the virus and inhibiting the viral attachment, and possessed prophylactic and therapeutic effects towards the virus. Our data indicate that the composite may provide new insights into antiviral therapy for RSV infection.

    Topics: Antiviral Agents; Cell Line; Curcumin; Graphite; Humans; Oxides; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses

2017
Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection.
    Nanoscale, 2016, Feb-07, Volume: 8, Issue:5

    Interactions between nanoparticles and viruses have attracted increasing attention due to the antiviral activity of nanoparticles and the resulting possibility to be employed as biomedical interventions. In this contribution, we developed a very simple route to prepare uniform and stable silver nanoparticles (AgNPs) with antiviral properties by using curcumin, which is a member of the ginger family isolated from rhizomes of the perennial herb Curcuma longa and has a wide range of biological activities like antioxidant, antifungal, antibacterial and anti-inflammatory effects, and acts as reducing and capping agents in this synthetic route. The tissue culture infectious dose (TCID50) assay showed that the curcumin modified silver nanoparticles (cAgNPs) have a highly efficient inhibition effect against respiratory syncytial virus (RSV) infection, giving a decrease of viral titers about two orders of magnitude at the concentration of cAgNPs under which no toxicity was found to the host cells. Mechanism investigations showed that cAgNPs could prevent RSV from infecting the host cells by inactivating the virus directly, indicating that cAgNPs are a novel promising efficient virucide for RSV.

    Topics: Antiviral Agents; Cell Line; Cell Survival; Curcumin; Drug Carriers; Dynamic Light Scattering; Humans; Interleukin-1beta; Interleukin-6; Metal Nanoparticles; Microscopy, Fluorescence; Photoelectron Spectroscopy; Real-Time Polymerase Chain Reaction; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; RNA, Messenger; Silver; Spectroscopy, Fourier Transform Infrared; Virus Internalization

2016